StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note issued to investors on Friday. The brokerage issued a sell rating on the biopharmaceutical company’s stock.
Aeterna Zentaris Trading Up 3.2 %
Shares of AEZS stock opened at $4.16 on Friday. Aeterna Zentaris has a 12-month low of $3.96 and a 12-month high of $12.00. The business’s fifty day simple moving average is $5.37 and its 200-day simple moving average is $6.79. The company has a market cap of $7.46 million, a PE ratio of -0.28 and a beta of 1.55.
About Aeterna Zentaris
Further Reading
- Five stocks we like better than Aeterna Zentaris
- When to Sell a Stock for Profit or Loss
- Powering Your Portfolio: The Utility Sector’s Electrifying Surge
- Earnings Per Share Calculator: How to Calculate EPS
- Adobe Stock Builds Long-Term Value: Consider Buying on the Dip
- Retail Stocks Investing, Explained
- Albemarle Jumps as Lithium Stock Buying Frenzy Takes Off
Receive News & Ratings for Aeterna Zentaris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aeterna Zentaris and related companies with MarketBeat.com's FREE daily email newsletter.